Drug
Turmetabart adizutecan clinical trials
Also written ABBV-706.
Keep track of what changes. Save the turmetabart adizutecan studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
- ABBV-706
- 4
Studies by the year they started
4 studies that test it; most in 2026 (3)
| Year | Studies |
|---|---|
| 2025 | 1 |
| 2026 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses turmetabart adizutecan is read from its arms, and is right about nine times in ten.
Testing it · 4
- A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) ABBV-706 in Combination With Alveltamig and Atezolizumab for Adults Participants With Extensive Stage-Small Cell Lung CancerNot yet recruitingPhase 2AbbVieNCT07895043Written as ABBV-706
- A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) ABBV-706 in Combination With Tarlatamab and Atezolizumab in Adult Participants With Extensive Stage-Small Cell Lung CancerNot yet recruitingPhase 2AbbVieNCT07895056Written as ABBV-706
- A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung CancerRecruitingPhase 2AbbVieNCT07155174Written as ABBV-706
- A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung CancerRecruitingPhase 3AbbVieNCT07365241Written as ABBV-706
Given in every arm · 1 — turmetabart adizutecan is usual care beside what is tested
Codes
What other systems call turmetabart adizutecan · ClinicalTrials.gg INT018108
- UNII (FDA) U9G63L4FA6TURMETABART ADIZUTECANOne source FDA
- NCI Thesaurus C198215Turmetabart AdizutecanOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | U9G63L4FA6 | TURMETABART ADIZUTECAN | One source FDA |
| NCI Thesaurus | C198215 | Turmetabart Adizutecan | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.